BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 31145528)

  • 1. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
    BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
    Abratt VR; Reid SJ
    Adv Appl Microbiol; 2010; 72():63-87. PubMed ID: 20602988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.
    Miller AW; Choy D; Penniston KL; Lange D
    Kidney Int; 2019 Jul; 96(1):180-188. PubMed ID: 31130222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: insights into understanding the rarity of urolithiasis in the black group.
    Magwira CA; Kullin B; Lewandowski S; Rodgers A; Reid SJ; Abratt VR
    J Appl Microbiol; 2012 Aug; 113(2):418-28. PubMed ID: 22616725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?
    Peck AB; Canales BK; Nguyen CQ
    Urolithiasis; 2016 Feb; 44(1):45-50. PubMed ID: 26645869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
    Vaidyanathan S; von Unruh GE; Watson ID; Laube N; Willets S; Soni BL
    ScientificWorldJournal; 2006 Apr; 6():2403-10. PubMed ID: 17619709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxalobacter formigenes produces metabolites and lipids undetectable in oxalotrophic Bifidobacterium animalis.
    Chamberlain CA; Hatch M; Garrett TJ
    Metabolomics; 2020 Nov; 16(12):122. PubMed ID: 33219444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
    BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an Innovative Method by Optimizing qPCR Technique for Isolating and Determining Oxalobacter Formigenes Microbial Load in the Stool of Patients with Urolithiasis.
    Jafari GA; Fotouhi Ardakani R; Akhavan Sepahi M; Nowroozi J; Soltanpour MS
    Iran J Kidney Dis; 2021 May; 15(3):190-198. PubMed ID: 33994378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sel1-like proteins and peptides are the major
    Arvans D; Chang C; Alshaikh A; Tesar C; Babnigg G; Wolfgeher D; Kron S; Antonopoulos D; Bashir M; Cham C; Musch M; Chang E; Joachimiak A; Hassan H
    Am J Physiol Cell Physiol; 2023 Jul; 325(1):C344-C361. PubMed ID: 37125773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist.
    Daniel SL; Moradi L; Paiste H; Wood KD; Assimos DG; Holmes RP; Nazzal L; Hatch M; Knight J
    Appl Environ Microbiol; 2021 Aug; 87(18):e0054421. PubMed ID: 34190610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs.
    Gnanandarajah JS; Abrahante JE; Lulich JP; Murtaugh MP
    Urol Res; 2012 Oct; 40(5):467-73. PubMed ID: 22223029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
    Hoppe B; von Unruh G; Laube N; Hesse A; Sidhu H
    Urol Res; 2005 Nov; 33(5):372-5. PubMed ID: 16284877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis.
    Batislam E; Yilmaz E; Yuvanc E; Kisa O; Kisa U
    Urol Res; 2012 Oct; 40(5):455-60. PubMed ID: 22215293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxalobacter formigenes--characteristics and role in development of calcium oxalate urolithiasis].
    Torzewska A
    Postepy Hig Med Dosw (Online); 2013 Nov; 67():1144-53. PubMed ID: 24379255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation.
    Mittal RD; Kumar R; Mittal B; Prasad R; Bhandari M
    Med Princ Pract; 2003; 12(4):208-13. PubMed ID: 12966191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures.
    Suryavanshi MV; Bhute SS; Jadhav SD; Bhatia MS; Gune RP; Shouche YS
    Sci Rep; 2016 Oct; 6():34712. PubMed ID: 27708409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones.
    Kaufman DW; Kelly JP; Curhan GC; Anderson TE; Dretler SP; Preminger GM; Cave DR
    J Am Soc Nephrol; 2008 Jun; 19(6):1197-203. PubMed ID: 18322162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.